Search Results 351-360 of 18189 for Immunode

1. A Study of ASTX660 Alone or Combined with ASTX727 in Subjects with Relapsed/Refractory Acute Myeloid Leukemia (AML) - Mayo Clinic

   Known human immunodeficiency virus (HIV), active hepatitis B virus (HBV), or active hepatitis C virus (HCV) infection (participants with laboratory evidence ...

2. A Study of SC-006 in Subjects With Advanced Cancer - Mayo Clinic

   History of primary immunodeficiency, allogeneic bone marrow transplantation, solid organ transplantation, or previous clinical diagnosis of tuberculosis.

3. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

   * Any form of primary immunodeficiency such as severe combined immunodeficiency disease * Current need of systemic corticosteroid therapy, in doses over 20 ...

4. Phase 3 Study Of Taletrectinib Vs Placebo As An Adjuvant Therapy In ROS1 Positive NSCLC (TRUST-IV) - Mayo Clinic

   ... immunodeficiency virus (HIV)- or acquired immunodeficiency syndrome-related illness. Currently have or have a history of interstitial lung disease (ILD) ...

5. A Study of SC‑004 in Subjects With Advanced Solid Tumors - Mayo Clinic

   History of primary immunodeficiency, allogeneic bone marrow transplantation, solid organ transplantation, or previous clinical diagnosis of tuberculosis.

6. A Study to Evaluate the Effectiveness and Safety of an Amikacin Liposome Inhalation Suspension-based Regimen in Adults with Nontuberculous Mycobacterial Lung Infection - Mayo Clinic

   - Administration of any investigational drug within 8 weeks prior to Screening. - Known or suspected acquired immunodeficiency syndromes (Human Immunodeficiency ...

7. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic researchers have unraveled the molecular mechanisms that affect which cells infected with human immunodeficiency virus (HIV) die and which ...

8. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   History of primary immunodeficiency. Severe, active co-morbidity defined as follows: Known clinically significant liver disease, including active viral ...

9. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   History of opportunistic infection or immunodeficiency syndrome. Currently on any chronic systemic (oral or intravenous) anti-infective therapy for chronic ...

10. A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ - Mayo Clinic

    * Immunocompromised patients including patients known to be human immunodeficiency virus (HIV) positive or those on chronic steroids * Note: Must be off ...